Thus, Medical professionals have shown that Foxp3+Treg expression is elevated in high-grade digestive malignant tumors, such as liver, pancreatic, and stomach cancers, and is typically linked to a poor prognosis for patients. Here, FOXP3 is linked to gastric cancer.